User contributions
From 2013.igem.org
(Latest | Earliest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)
- 02:13, 5 October 2013 (diff | hist) Team:Warsaw/Cooperation with PWN (→Synthetic biology - HUB) (top)
- 02:08, 5 October 2013 (diff | hist) Team:Warsaw/Cooperation with PWN (→Genes and machines)
- 01:59, 5 October 2013 (diff | hist) Team:Warsaw/Strategy overview (→What have we done to make young people in Poland more aware?)
- 01:52, 5 October 2013 (diff | hist) Team:Warsaw/Strategy overview (→Why did we choose acrylamide and biosafety as our Human Practice main theme?)
- 01:45, 5 October 2013 (diff | hist) Team:Warsaw/Strategy overview (→Who was our target?)
- 01:39, 5 October 2013 (diff | hist) Team:Warsaw/Strategy overview (→We asked ourselves...)
- 01:35, 5 October 2013 (diff | hist) Team:Warsaw/Strategy overview (→What seems to be the problem?)
- 01:29, 5 October 2013 (diff | hist) Team:Warsaw/Strategy overview
- 00:43, 5 October 2013 (diff | hist) Team:Warsaw/Acknowledgments (→Acknowledgments)
- 00:38, 5 October 2013 (diff | hist) Team:Warsaw/Protocols
- 00:38, 5 October 2013 (diff | hist) Team:Warsaw/Protocols (→Chemocompetent bacteria)
- 00:37, 5 October 2013 (diff | hist) Team:Warsaw/Protocols (→Chemocompetent bacteria)
- 00:34, 5 October 2013 (diff | hist) Team:Warsaw/Safety (→Part 3)
(Latest | Earliest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)